Synthesis of Novel ent-Kaurane-Type Diterpenoid Derivatives Effective for Highly Aggressive Tumor Cells
Hu, Yu1; Li, Xiao-Nian2; Ma, Ze-Jin1; Puno, Pema-Tenzin2; Zhao, Yong1; Zhao, Yan1; Xiao, Ye-Zhi1; Zhang, Wei1; Liu, Jing-Ping1
2018-12-01
发表期刊MOLECULES
ISSN1420-3049
卷号23期号:12页码:9
摘要We have designed and synthesized 6 ent-Kaurane-type diterpenoid derivatives containing ,-unsaturated ketone moieties. In vitro, activity was evaluated against three human tumor cell lines and a rat myogenic cell line (HepG2, NSCLC-H292, SNU-1040, L6) by MTT assay. All the tested compounds exhibited comparable or higher activity than DDP and eriocalyxin B. Compounds 16, 17 and 18 are promising anti-tumor leads due to their cytotoxic potencies and higher selectivity, with SI values of 161.06, 47.80 and 128.20, respectively.
关键词ent-kaurane-type diterpenoid derivatives antitumor synthesis
收录类别SCI
语种英语
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/64301
专题植物化学与西部植物资源持续利用国家重点实验室
通讯作者Puno, Pema-Tenzin; Liu, Jing-Ping
作者单位1.Yunnan Normal Univ, Dept Chem, Kunming 650092, Yunnan, Peoples R China
2.Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West C, Kunming 650201, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Hu, Yu,Li, Xiao-Nian,Ma, Ze-Jin,et al. Synthesis of Novel ent-Kaurane-Type Diterpenoid Derivatives Effective for Highly Aggressive Tumor Cells[J]. MOLECULES,2018,23(12):9.
APA Hu, Yu.,Li, Xiao-Nian.,Ma, Ze-Jin.,Puno, Pema-Tenzin.,Zhao, Yong.,...&Liu, Jing-Ping.(2018).Synthesis of Novel ent-Kaurane-Type Diterpenoid Derivatives Effective for Highly Aggressive Tumor Cells.MOLECULES,23(12),9.
MLA Hu, Yu,et al."Synthesis of Novel ent-Kaurane-Type Diterpenoid Derivatives Effective for Highly Aggressive Tumor Cells".MOLECULES 23.12(2018):9.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hu, Yu]的文章
[Li, Xiao-Nian]的文章
[Ma, Ze-Jin]的文章
百度学术
百度学术中相似的文章
[Hu, Yu]的文章
[Li, Xiao-Nian]的文章
[Ma, Ze-Jin]的文章
必应学术
必应学术中相似的文章
[Hu, Yu]的文章
[Li, Xiao-Nian]的文章
[Ma, Ze-Jin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。